OpenAlex
Works that cite this article, indexed by OpenAlex.
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Journal of Hematology & Oncology 14(1) (2021)
Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
Aging and Disease 15(2) (2024)
Ka Iong Chan; Siyuan Zhang; Guodong Li; Yida Xu; Liao Cui; Yitao Wang; Huanxing Su; Wen Tan; Zhangfeng Zhong
Noncanonical activation of GLI signaling in SOX2 + cells drives medulloblastoma relapse
Science Advances 8(29) (2022)
Marzena Swiderska‐Syn; Júlia Mir-Pedrol; Alexander R. Oles; Olga Schleuger; April Salvador; Sean M. Greiner; Cara Seward; Fan Yang; Benjamin R. Babcock; Chen Shen; Daniel T. Wynn; Avencia Sánchez-Mejías; Timothy R. Gershon; Vanesa Martı́n; Heather J. McCrea; Kathryn Lindsey; Carsten Krieg; Jezabel Rodríguez‐Blanco
Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
Journal of Healthcare Engineering 2022 (2022)
Linzhang Li; Chengwu Han; Xueying Yu; Jun Shen; Yongtong Cao
Anti-Leukemic Effects of Small Molecule Inhibitor of c-Myc (10058-F4) on Chronic Myeloid Leukemia Cells
Asian Pacific Journal of Cancer Prevention 25(6) (2024)
Sara Zehtabcheh; Negar Sheikh‐Zeineddini; Amir‐Mohammad Yousefi; Davood Bashash
Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519.
PubMed 19(3) (2020)
Atieh Pourbagheri‐Sigaroodi; Ava Safaroghli‐Azar; Mehrnoosh Shanaki; Amir‐Mohammad Yousefi; Ali Anjam-Najmedini; Davood Bashash